Second insulin pump safety meeting: summary report.
Zhang
Yi
Y
Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland 20993-002 , USA. Yi.Zhang2@fda.hhs.gov
Jones
Paul L
PL
Klonoff
David C
DC
D001331:Automation; D003920:Diabetes Mellitus / Q000188:drug therapy; D004738:Engineering / Q000592:standards; D004867:Equipment Design; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D015918:Infusion Pumps, Implantable / Q000592:standards; D007328:Insulin / Q000008:administration & dosage; D007332:Insulin Infusion Systems / Q000592:standards*; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration; D014584:User-Computer Interface
D007004:Hypoglycemic Agents; D007328:Insulin